Literature DB >> 23570315

The genetics of innate immunity sensors and human disease.

Julien Pothlichet1, Lluis Quintana-Murci.   

Abstract

Since their discovery, innate immunity microbial sensors have been increasingly studied and shown to play a critical role in innate responses to microbes in several experimental in vitro, ex vivo, and animal models. However, their role in the human response to infection in natural conditions has just started to be deciphered, by means of clinical studies of primary immunodeficiencies and epidemiological genetic studies. Here, we summarize the major findings concerning the genetic diversity of the various families of microbial sensors in humans, and of other molecules involved in the signaling pathways they trigger. Specifically, we review the genetic associations, revealed by both clinical and epidemiological genetics studies, of microbial sensors from five different families: Toll-like receptors, C-type lectin receptors, NOD-like receptors, RIG-I-like receptors, and cytosolic DNA sensors. In particular, we consider the relationships between variation at the genes encoding these molecules and susceptibility to and the severity of infectious diseases and other clinical conditions associated with immune dysfunction, including autoimmunity, inflammation, allergy, and cancer. Despite the fact that the genetic links between innate immunity sensors and human disorders remain still limited, human genetics studies are increasingly improving our understanding of the genuine functions of microbial sensors and downstream signaling molecules in the natural setting.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23570315     DOI: 10.3109/08830185.2013.777064

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  11 in total

1.  Inflammatory Markers in Recent Onset Psychosis and Chronic Schizophrenia.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Jennifer Schroeder; Emily Katsafanas; Lucy Schweinfurth; Christina Savage; Sunil Khushalani; Robert Yolken
Journal:  Schizophr Bull       Date:  2015-08-19       Impact factor: 9.306

2.  Polymorphisms in Receptors Involved in Opsonic and Nonopsonic Phagocytosis, and Correlation with Risk of Infection in Oncohematology Patients.

Authors:  M Carmen Herrero-Sánchez; Eduardo B Angomás; Cristina de Ramón; Juan J Tellería; Luis A Corchete; Sara Alonso; M Del Carmen Ramos; María J Peñarrubia; Saioa Márquez; Nieves Fernández; Luis J García Frade; Mariano Sánchez Crespo
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

3.  The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis.

Authors:  Deepak Bharti; Ashish Kumar; Ranjeet Singh Mahla; Sushil Kumar; Harshad Ingle; Hari Shankar; Beenu Joshi; Ashwin Ashok Raut; Himanshu Kumar
Journal:  Immunogenetics       Date:  2014-09-25       Impact factor: 2.846

Review 4.  Reservoir host immune responses to emerging zoonotic viruses.

Authors:  Judith N Mandl; Rafi Ahmed; Luis B Barreiro; Peter Daszak; Jonathan H Epstein; Herbert W Virgin; Mark B Feinberg
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

5.  Multiple Infectious Complications in a Severely Injured Patient with Single Nucleotide Polymorphisms in Important Innate Immune Response Genes.

Authors:  Maarten W G A Bronkhorst; Peter Patka; Esther M M Van Lieshout
Journal:  Open Orthop J       Date:  2015-07-31

6.  Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides.

Authors:  Guanghui Yi; Volker P Brendel; Chang Shu; Pingwei Li; Satheesh Palanathan; C Cheng Kao
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

Review 7.  Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators.

Authors:  Elke S Bergmann-Leitner; Wolfgang W Leitner
Journal:  Vaccines (Basel)       Date:  2014-04-10

8.  RNA virus attenuation by codon pair deoptimisation is an artefact of increases in CpG/UpA dinucleotide frequencies.

Authors:  Fiona Tulloch; Nicky J Atkinson; David J Evans; Martin D Ryan; Peter Simmonds
Journal:  Elife       Date:  2014-12-09       Impact factor: 8.140

9.  Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient.

Authors:  Jennifer Harcourt; Azaibi Tamin; Xiaoyan Lu; Shifaq Kamili; Senthil Kumar Sakthivel; Janna Murray; Krista Queen; Ying Tao; Clinton R Paden; Jing Zhang; Yan Li; Anna Uehara; Haibin Wang; Cynthia Goldsmith; Hannah A Bullock; Lijuan Wang; Brett Whitaker; Brian Lynch; Rashi Gautam; Craig Schindewolf; Kumari G Lokugamage; Dionna Scharton; Jessica A Plante; Divya Mirchandani; Steven G Widen; Krishna Narayanan; Shinji Makino; Thomas G Ksiazek; Kenneth S Plante; Scott C Weaver; Stephen Lindstrom; Suxiang Tong; Vineet D Menachery; Natalie J Thornburg
Journal:  bioRxiv       Date:  2020-03-07

10.  NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway.

Authors:  Xiaomin Ma; Yumin Qiu; Yanlin Sun; Lihui Zhu; Yunxue Zhao; Tao Li; Yueke Lin; Dapeng Ma; Zhenzhi Qin; Caiyu Sun; Lihui Han
Journal:  Cell Death Dis       Date:  2020-03-06       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.